Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;56(6):761-768.
doi: 10.5946/ce.2022.297. Epub 2023 Jul 25.

Self-expandable metallic stent-induced esophagorespiratory fistulas in patients with advanced esophageal cancer

Iatagan R Josino  1 , Bruno C Martins  1 , Andressa A Machado  1 , Gustavo R de A Lima  1 , Martin A C Cordero  1 , Amanda A M Pombo  1 , Rubens A A Sallum  1 , Ulysses Ribeiro Jr  1 , Todd H Baron  2 , Fauze Maluf-Filho  1   3   4
Affiliations

Self-expandable metallic stent-induced esophagorespiratory fistulas in patients with advanced esophageal cancer

Iatagan R Josino et al. Clin Endosc. 2023 Nov.

Abstract

Background/aims: Self-expandable metallic stents (SEMSs) are widely adopted for the palliation of dysphagia in patients with malignant esophageal strictures. An important adverse event is the development of SEMS-induced esophagorespiratory fistulas (SEMS-ERFs). This study aimed to assess the risk factors related to the development of SEMS-ERF after SEMS placement in patients with esophageal cancer.

Methods: This retrospective study was performed at the Instituto do Cancer do Estado de São Paulo. All patients with malignant esophageal strictures who underwent esophageal SEMS placement between 2009 and 2019 were included in the study.

Results: Of the 335 patients, 37 (11.0%) developed SEMS-ERF, with a median time of 129 days after SEMS placement. Stent flare of 28 mm (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.15-5.51; p=0.02) and post-stent chemotherapy (HR, 2.0; 95% CI, 1.01-4.00; p=0.05) were associated with an increased risk of developing SEMS-ERF, while lower-third tumors were a protective factor (HR, 0.5; 95% CI, 0.26-0.85; p=0.01). No difference was observed in overall survival.

Conclusion: The incidence of SEMS-ERFs was 11%, with a median time of 129 days after SEMS placement. Post-stent chemotherapy and a 28 mm stent flare were associated with a higher risk of SEMS-ERF.

Keywords: Esophageal fistula; Esophageal neoplasms; Self-expandable metallic stents.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no potential conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Bronchoscopy showing the proximal flare of an esophageal Self-expandable metal stent partially inside the tracheal lumen.
Fig. 2.
Fig. 2.
Flowchart of patients included in the study. SEMS, self-expandable metallic stent; SEMS-ERF, SEMS-induced esophagorespiratory fistula.
Fig. 3.
Fig. 3.
Kaplan-Meier overall survival curve. (A) All patients included. (B) Only patients with squamous cell carcinoma.
None
See this image and copyright information in PMC

Comment in

References

    1. Napier KJ, Scheerer M, Misra S. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 2014;6:112–120. - PMC - PubMed
    1. Parker RK, White RE, Topazian M, et al. Stents for proximal esophageal cancer: a case-control study. Gastrointest Endosc. 2011;73:1098–1105. - PubMed
    1. Medeiros VS, Martins BC, Lenz L, et al. Adverse events of self-expandable esophageal metallic stents in patients with long-term survival from advanced malignant disease. Gastrointest Endosc. 2017;86:299–306. - PubMed
    1. Homann N, Noftz MR, Klingenberg-Noftz RD, et al. Delayed complications after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci. 2008;53:334–340. - PubMed
    1. Lenz CJ, Bick BL, Katzka D, et al. Esophagorespiratory fistulas: survival and outcomes of treatment. J Clin Gastroenterol. 2018;52:131–136. - PubMed

LinkOut - more resources